Patents by Inventor Mumtaz Ahmed

Mumtaz Ahmed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition and process for prevention and treatment of cutaneous immediate hypersensitivity reactions
    Patent number: 5684038
    Abstract: A process and pharmaceutical composition for the prevention and treatment of cutaneous Type I hypersensitivity reactions in humans is disclosed. The pharmaceutical composition comprises of a chromone compound of the following formula, or a pharmacologically acceptable salt, ester or amide thereof: ##STR1## dissolved or dispersed in a pharmacologically acceptable carrier. In accordance with the process, a preventively or therapeutically effective amount of the composition is topically administered to a human patient, as required; i.e. for prevention the composition is administered to the area of skin susceptible to exposure to antigen and for treatment the composition is administered to the reaction site.
    Type: Grant
    Filed: June 28, 1996
    Date of Patent: November 4, 1997
    Assignee: Ascent Pharmaceuticals, Inc.
    Inventors: Emmett Clemente, Robert W. Mendes, Aloysius O. Anaebonam, Mumtaz Ahmed
  • Composition and process for prevention and treatment of cutaneous immediate hypersensitivity reactions
    Patent number: 5684037
    Abstract: A process and pharmaceutical composition for the prevention and treatment of cutaneous Type I hypersensitivity reactions in humans is disclosed. The pharmaceutical composition comprises of a chromone compound of the following formula, or a pharmacologically acceptable salt, ester or amide thereof: ##STR1## dissolved or dispersed in a pharmacologically acceptable carrier. In accordance with the process, a preventively or therapeutically effective amount of the composition is topically administered to a human patient, as required; i.e. for prevention the composition is administered to the area of skin susceptible to exposure to antigen and for treatment the composition is administered to the reaction site.
    Type: Grant
    Filed: June 28, 1996
    Date of Patent: November 4, 1997
    Assignee: Ascent Pharmaceuticals, Inc.
    Inventors: Emmett Clemente, Robert W. Mendes, Aloysius O. Anaebonam, Mumtaz Ahmed
  • Process for treating uremic pruritus
    Patent number: 5576346
    Abstract: A process and pharmaceutical composition for treatment of uremic pruritus in humans is disclosed. The pharmaceutical composition comprises of a chromone compound of the following formula, or a pharmacologically acceptable salt, ester or amide thereof: ##STR1## dissolved or dispersed in a pharmacologically acceptable carrier. In accordance with the process, a therapeutically effective amount of the composition is topically administered to a pruritic lesion of a human patient.
    Type: Grant
    Filed: April 3, 1995
    Date of Patent: November 19, 1996
    Assignee: Ascent Pharmaceuticals, Inc.
    Inventors: Emmett Clemente, Robert W. Mendes, Aloysius O. Anaebonam, Mumtaz Ahmed
  • Process for treating hemangioma
    Patent number: 5552436
    Abstract: A process and pharmaceutical composition for treatment of hemangioma in humans is disclosed. The pharmaceutical composition comprises a chromone compound of the following formula, or a pharmacologically acceptable salt, ester or amide thereof: ##STR1## dissolved or dispersed in a pharmacologically acceptable carrier. In accordance with the process, a therapeutically effective amount of the composition is topically administered to a hemangioma of a human patient.
    Type: Grant
    Filed: April 3, 1995
    Date of Patent: September 3, 1996
    Assignee: Ascent Pharmaceuticals, Inc.
    Inventors: Emmett Clemente, Robert W. Mendes, Aloysius O. Anaebonam, Mumtaz Ahmed
  • Composition and process for prevention and treatment of cutaneous immediate hypersensitivity reactions
    Patent number: 5532270
    Abstract: A process and pharmaceutical composition for the prevention and treatment of cutaneous Type I hypersensitivity reactions in humans is disclosed. The pharmaceutical composition comprises of a chromone compound of the following formula, or a pharmacologically acceptable salt, ester or amide thereof: ##STR1## dissolved or dispersed in a pharmacologically acceptable carrier. In accordance with the process, a preventively or therapeutically effective amount of the composition is topically administered to a human patient, as required; i.e. for prevention the composition is administered to the area of skin susceptible to exposure to antigen and for treatment the composition is administered to the reaction site.
    Type: Grant
    Filed: April 3, 1995
    Date of Patent: July 2, 1996
    Assignee: Ascent Pharmaceuticals, Inc.
    Inventors: Emmett Clemente, Robert W. Mendes, Aloysius O. Anaebonam, Mumtaz Ahmed